Pangaea Oncology SA logo

PANG - Pangaea Oncology SA News Story

€2 0.1  2.6%

Last Trade - 14/05/21

Sector
Healthcare
Size
Micro Cap
Market Cap £32.3m
Enterprise Value £35.1m
Revenue £3.53m
Position in Universe 507th / 726

BRIEF-Pangaea Oncology Signs Deal With Oryzon Genomics To Provide Diagnostic Services

Tue 10th July, 2018 8:58am
July 10 (Reuters) - Pangaea Oncology SA  PANGO.MC :
    * SIGNS DEAL WITH ORYZON GENOMICS TO PROVIDE DIAGNOSTIC
SERVICES
    * SERVICES RELATED TO VALIDATION OF MARKERS IN LUNG CANCER
ASSOCIATED WITH DEVELOPMENT OF ORY-1001 DRUG

Source text: https://bit.ly/2KMxMZZ
    
Further company coverage:  PANGO.MC 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.